Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Schedule of the Effect of Corrections A summary of the effect of the corrections on the condensed consolidated statements of operations for the three and nine months ended October 31, 2021 were as follows (in thousands, except per share data):
Three Months Ended October 31, 2021
Nine Months Ended October 31, 2021
As reported Corrections As Adjusted As reported Corrections As Adjusted
Operating expenses:
Research and development $ 16,621  $ (30) $ 16,591  $ 44,836  $ (119) $ 44,717 
Sales and marketing 76,191  (1,493) 74,698  207,079  (2,506) 204,573 
Total operating expenses 114,645  (1,523) 113,122  315,279  (2,625) 312,654 
Operating loss (26,289) 1,523  (24,766) (66,299) 2,625  (63,674)
Loss before provision for income taxes (27,408) 1,523  (25,885) (71,043) 2,625  (68,418)
Net loss (29,231) 1,523  (27,708) (77,175) 2,625  (74,550)
Net loss per share attributable to Class A and Class B stockholders, basic and diluted $ (0.11) $ —  $ (0.11) $ (0.44) $ 0.01  $ (0.43)
A summary of the effect of the corrections on the condensed consolidated statements of cash flows for the nine months ended October 31, 2021 were as follows (in thousands):
Nine Months Ended October 31, 2021
As reported Corrections As Adjusted
Net loss (77,175) 2,625  (74,550)
Changes in operating assets and liabilities
Prepaid expenses and other current assets (1,104) (1,291) (2,395)
Other non-current assets (1,817) (1,334) (3,151)